US 11192886
S1P1 agonist and application thereof
granted A61PA61P37/02
Quick answer
US patent 11192886 (S1P1 agonist and application thereof) held by Medshine Discovery Inc. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61P, A61P37/02